Edition:
United States

Novelion Therapeutics Inc (NVLN.OQ)

NVLN.OQ on NASDAQ Stock Exchange Global Select Market

3.35USD
11:28am EDT
Change (% chg)

$-0.07 (-2.05%)
Prev Close
$3.42
Open
$3.49
Day's High
$3.58
Day's Low
$3.31
Volume
2,430
Avg. Vol
25,706
52-wk High
$9.58
52-wk Low
$3.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 27.48 -1.755
FY 2017 Dec '17 38.91 -1.316
Sep '17 28.67 -2.668
Jun '17 40.88 -1.152
Mar '17 29.98 -1.670
FY 2016 Dec '16 13.57 -1.482
Sep '16 0.00 -0.562
Jun '16 0.00 -0.485
Mar '16 0.00 -2.072
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 35.05 36.20 33.90 --
Quarter Ending Dec-18 2 41.30 42.30 40.30 --
Year Ending Dec-18 2 138.90 139.00 138.80 189.71
Year Ending Dec-19 2 167.60 184.80 150.40 212.13
Earnings (per share)
Quarter Ending Sep-18 1 -0.07 -0.07 -0.07 --
Quarter Ending Dec-18 1 0.14 0.14 0.14 --
Year Ending Dec-18 1 -1.53 -1.53 -1.53 -0.30
Year Ending Dec-19 1 1.24 1.24 1.24 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 214.53 33.05
P/E High - Last 5 Yrs. -- 284.38 47.17
P/E Low - Last 5 Yrs. -- 96.91 24.95
Beta 0.91 0.76 0.81
Price to Sales (TTM) 0.49 254.39 8.10
Price to Book (MRQ) -- 21.00 4.20
Price to Tangible Book (MRQ) -- 27.24 6.22
Price to Cash Flow (TTM) -- 130.02 22.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.74
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.25 -6.34
Payout Ratio(TTM) -- 83.66 47.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -8.34 33.06 4.76
Sales (TTM) vs TTM 1 Yr. Ago 212.09 147.32 12.20
Sales - 5 Yr. Growth Rate -- 30.74 7.68
EPS (MRQ) vs Qtr. 1 Yr. Ago -5.10 -78.41 49.25
EPS (TTM) vs TTM 1 Yr. Ago -64.12 -- --
EPS - 5 Yr. Growth Rate -- 46.75 7.98
Capital Spending - 5 Yr. Growth Rate -3.31 42.59 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.42 1.72 2.56
Current Ratio (MRQ) 1.65 6.63 3.63
LT Debt to Equity (MRQ) -- 24.37 13.18
Total Debt to Equity (MRQ) -- 28.57 17.32
Interest Coverage (TTM) -4.72 -156.06 35.18

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 45.36 55.96 55.27
Gross Margin - 5 Yr. Avg. -- 53.49 53.21
EBITD Margin (TTM) -42.96 -- --
EBITD - 5 Yr. Avg -118.62 -180.79 15.63
Operating Margin (TTM) -63.71 -952.42 -0.59
Operating Margin - 5 Yr. Avg. -117.86 -194.47 10.78
Pre-Tax Margin (TTM) -94.14 -846.49 1.29
Pre-Tax Margin - 5 Yr. Avg. -151.93 -199.31 10.90
Net Profit Margin (TTM) -94.58 -837.92 -2.01
Net Profit Margin - 5 Yr. Avg. -152.90 -197.08 7.26
Effective Tax Rate (TTM) -- 14.85 20.80
Effective Tax Rate - 5 Yr. Avg. -- 19.02 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 755,211 23,390,416 736,883,287
Net Income/Employee (TTM) -714,311 -1,131,911 85,936,826
Receivable Turnover (TTM) 9.88 17.85 5.95
Inventory Turnover (TTM) 4.03 2.85 3.69
Asset Turnover (TTM) 0.34 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -31.92 -2.22 10.35
Return on Assets - 5 Yr. Avg. -17.40 2.95 11.02
Return on Investment (TTM) -40.08 -3.67 13.17
Return on Investment - 5 Yr. Avg. -19.90 2.77 14.24
Return on Equity (TTM) -273.91 -5.61 15.10
Return on Equity - 5 Yr. Avg. -29.31 -4.39 15.57
  1 Year 3 Year 5 Year
Sales % 919.88 -- --
EPS (TTM) % -45.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Novelion Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.79 -7.62 36 39
13 Week -22.27 -25.36 20 61
26 Week -11.63 -11.83 44 70
52 Week -63.34 -67.67 10 84
YTD 9.62 4.50 61 85
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 80.70%
# of Holders: 94
Total Shares Held: 15,214,103
3 Mo. Net Change: -4,544
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 3
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.